Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Enrico Vigna"'
Autor:
Lena Kasper, Frederic Pipp, Bettina Hanschke, Michael Schmitt, Stephanie Czasch, Enrico Vigna, Anindya Siddharta, Stefan Weigt, Barbara Emde, Jürgen Hellmann, Sven Jäckel
Publikováno v:
Journal of pharmacological and toxicological methods. 110
Introduction Gastrointestinal (GI) toxicity is still an issue within drug development, especially for novel oncology drugs. The identification of GI mucosal damage at an early stage with high sensitivity and specificity across preclinical species and
Autor:
Enrico Vigna, Manuela Onidi, Juergen Hellmann, Anja Knippel, Andrea Paoletti, Ping Yu, Christina Esdar
Publikováno v:
Toxicology and applied pharmacology. 406
Blocking Fibroblast Growth Factor Receptor 1 (FGFR1) is an attractive therapeutic option for treatment of cancer subtypes with amplification and over-expression of FGFR1. Selective targeting of FGFR1 can be achieved using an antibody-based approach,
Autor:
Enrico Vigna
Publikováno v:
HISTORIA MAGISTRA. :108-112
Autor:
Derek Janszen, Enrico Vigna, Sergio Peano, Manuela Onidi, Mauro Bertolino, Rafael A. Ponce, Chiara Daghero, Laura Fava, Ping Yu, Jennifer Visich, Michela Carbonatto, Stephanie Steidler, Bruno Roattino, Stacey R. Dillon, Michele Ardizzone
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 105(1)
Atacicept, a soluble recombinant fusion protein of the human immunoglobulin (Ig) G1 Fc and the extracellular domain of the human transmembrane activator and calcium modulator and cyclophylin ligand interactor receptor, acts as an antagonist of both B
Autor:
Michela Carbonatto, Ping Yu, Mauro Bertolino, Enrico Vigna, Stephanie Steidler, Laura Fava, Chiara Daghero, Bruno Roattino, Manuela Onidi, Michele Ardizzone, Sergio Peano, Jennifer Visich, Derek Janszen, Stacey Dillon, Rafael Ponce
Publikováno v:
Toxicological Sciences; Sep2008, Vol. 105 Issue 1, p200-200, 1p